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1169-153 Intra-Aortic Balloon Counterpulsation Improves 
Regional Systolic Function After Acute Myocardial 
Infarction: Randomized Experimental Magnetic 
Resonance Imaging Study
Clerio F. Azevedo, Luciano C. Amado, Dara L. Kraitchman, Bernhard L. Gerber, Nael F. 
Osman, Carlos E. Rochitte, Katherine C. Wu, Joao A. Lima, Johns Hopkins Hospital, 
Baltimore, MD
Background: We investigated whether the favorable shift in the myocardial oxygen sup-
ply/demand ratio afforded by intraaortic balloon counterpulsation (IABP) translates into
improved regional systolic function after acute myocardial infarction (AMI).
Methods: Fourteen dogs underwent 90-min coronary artery occlusion and reperfusion.
Seven were randomized to IABP immediately after reperfusion. Five short-axis slices
were acquired for each dog at 1h, 6h and 24h following reperfusion using both delayed-
enhancement (DE) and tagged MRI. IABP was paused during image acquisition. The risk
region was defined as regional blood flow <50% of remote by radioactive microspheres.
Each slice was divided into 6 segments that were classified in 4 categories: transmural
AMI (DE>50% area), subendocardial AMI (DE<50% area), risk region and remote area.
Peak systolic circumferential strain (Ecc) was calculated for each segment.
Results: Among segments with transmural AMI there was no difference in Ecc between
the IABP group and controls (1±3% vs 1±3% at 1h, 0±4% vs 0±3% at 6h and 0±3% vs
0±3% at 24h, NS for all) and no Ecc improvement over time. Among subendocardial AMI
segments, at 24h after reperfusion, the IABP group exhibited higher Ecc values than con-
trols (–2±4% vs –3±3% at 1h, NS, –2±4% vs –2±4% at 6h, NS and –6±3% vs –4±3%,
P<0.01), and only the IABP group had a significant improvement in Ecc from 1h or 6h to
24h (P<0.001). Among risk region segments, both groups displayed significant systolic
dysfunction at 1h, and recovered normal contractility at 24h. At 6h, however, the IABP
group exhibited normal contractility while controls still displayed systolic dysfunction (–
5±4% vs –5±3% at 1h, NS, –12±5% vs –6±3% at 6h, P<0.001 and –14±5% vs –13±4%
at 24h, NS). Therefore, both groups showed a significant Ecc improvement over time in
risk regions, but the improvement occurred earlier in the IABP group. Both groups dis-
played normal Ecc values in remote segments at all times (–13±5% vs –12±5% at 1h, –
14±6% vs –13±5% at 6h, and –13±5% vs –13±5% at 24h, NS for all).
Conclusion: IABP has a direct beneficial effect on regional functional recovery of seg-
ments that are predominantly composed of stunned myocardium after reperfused AMI.
1169-154 Steady State Free Precession Perfusion Allows Visual 
Assessment for the Clinical Diagnosis of Ischemia
Nico Merkle, Thorsten Nusser, Jochen Wöhrle, Hans A. Kestler, Bernhard 
Schnackenburg, Martin Höher, Matthias Kochs, Vinzenz Hombach, Olaf Grebe, 
University of Ulm, Ulm, Germany
Cardiac magnetic resonance imaging (MRI) is a powerful tool for the non-invasive exami-
nation of myocardial perfusion. Apart from the determination of wall motion the assess-
ment of coronary perfusion at rest and during pharmacological stress is a very reliable
method for the detection of myocardial ischemia. Semi quantitative analysis (assessment
of the myocardial signal up-slope and the response of blood supply to stress) is too elab-
orate for the use in clinical routine. However, conventional techniques are hampered by
artifacts and a poor signal-to-noise-ratio impeding visual assessment. Steady-state-free-
precession (SSFP) sequences are a new technique with a better spatial resolution. The
aim of this study was to assess diagnostic accuracy of SSFP.
Methods: 137 patients (mean 61 years, 85% male) with suspected coronary heart dis-
ease or suspected progression were examined by cardiac MRI (1,5T Philips Intera CV).
All patients underwent coronary angiography. For the assessment of myocardial perfu-
sion a SSFP-sequence with a slice selective saturation-recovery-prepulse (3 slice-cover-
age of left ventricle per heartbeat) was employed and pharmacological stress was
performed by using adenosine(140µg/kg/min). The analysis was performed without
knowledge of the angiographic findings.
Results: 85 of 94 patients with significant stenosis (>70% diameter stenosis) in invasive
angiography showed stress related attenuated perfusion in MRI indicating ischemia (sen-
sitivity 90%). Only 5 out of 38 patients with no significant stenosis in coronary angiogra-
phy showed attenuated appearance of contrast in MRI (specificity 88%). Among those 2
patients had hypertonia , 2 patients showed pathological exercise testing and 1 patient
had no stenosis although presenting 2 lesions in scar imaging.
5/85 patients with a visible perfusion defect in MRI showed no relevant stenosis in
angiography (positive correctness 94%). 9/38 patients with no attenuated perfusion in
MRI showed a significant stenosis in coronary angiography (negative correctness 81%).
Conclusion: SSFP-sequences with visual assessment of perfusion defects allow a reli-
able detection of relevant myocardial ischemia from cardiac MRI.
1169-155 Gadolinium-Enhanced Magnetic Resonance Imaging in 
Patients With Left Ventricular Apical Ballooning 
Syndrome Identifies Acute Myocarditis as a Potential 
Etiology of This Syndrome
Christian F. Witzke, Godtfred Holmvang, Gregory D. Lewis, Nadeem Afridi, Marc J. 
Semigran, G. William Dec, Igor F. Palacios, Massachusetts General Hospital, Boston, MA
Background: Gadolinium-enhanced cardiac MRI (Gd-MRI) is a new non-invasive diag-
nostic tool to identify patients with acute myocarditis. Left ventricular apical ballooning
syndrome (LVABS) is a clinical condition of unknown etiology characterized by acute
onset of abnormal apical wall motion in the presence of angiographically normal coro-
nary arteries. To test the hypothesis that acute myocarditis may be the etiology of this
syndrome, Gd-MRI was performed as described by Friedrich et al (Circulation
1998;97:1802) in 11 consecutive patients who presented to Massachusetts General Hos-
pital between January 2000 and January 2002 with LVABS. Methods. The ratio of global
enhancement of myocardium relative to skeletal muscle was calculated from T1-
weighted spin-echo images acquired before and after administration of 0.1mmol/kg of Gd
intravenously. The Gd-MRI study was considered positive for myocarditis when this ratio
was > 3.5. Because myocarditis can be a focal disease, we also calculated a regional rel-
ative enhancement ratio (RRER) within the area of abnormal wall motion. Results. All
patients were female (mean age of 72 ± 11 years) who presented with acute onset of
chest pain, ST segment elevation, extensive anterior and apical wall motion abnormali-
ties, elevated cardiac enzymes and angiographically normal coronary arteries. Global
MRI analysis was positive for myocarditis in 5/11 patients (45.5%, mean value of 4.8 ±
1.4 at 5 ± 2 days after admission). Regional MRI analysis identified 4 additional patients
with myocarditis (mean RRER 4.1 ± 0.6). The mean left ventricular ejection fraction was
41 ± 12% at the time of admission, 52 ± 14% at the time of hospital discharge, and 70.2
± 8% at 39 ± 43 days of follow-up. Conclusion: 1) LVABS is characterized by acute
onset of chest pain associated with abnormal apical wall motion and myonecrosis in the
presence of normal coronary arteries, followed by rapid improvement in LV systolic func-
tion. 2) Gd-MRI suggests that acute myocarditis is a possible underlying mechanism for
the LVABS. 3) Because myocarditis can be a focal disease, regional Gd-MRI analysis
adds sensitivity to global Gd-MRI analysis in this cohort of patients.
1169-156 Usefulness of Myocardial Delayed Enhancement 
Magnetic Resonance in the Diagnosis and Surgical 
Treatment of Endomyocardial Fibrosis
Vera M C Salemi, Carlos E. Rochitte, Sergio A. Oliveira, Joalbo M. Andrade, Charles 
Mady, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
Background: Endomyocardial fibrosis (EMF) is a rare restrictive cardiomyopathy, whose
differential diagnosis includes cardiac diseases with apical obliteration. The treatment is
fibrous tissue (FT) resection in symptomatic patients (pts). Myocadial delayed enhance-
ment (MDE) magnetic resonance with gadolinium-based contrast (Gd) allows the detec-
tion of myocardial injury and fibrosis. Therefore, the aim of this study was to analyze the
utility of MDE in patients with EMF.
Methods: We studied prospectively 24 pts (19 females, 58±11 years) with EMF, 4 (17%)
with predominant right ventricular (RV) involvement, 12 (50%) with predominant left ven-
tricular (LV) involvement and 8 (33%) with biventricular involvement. Six (25%) of these
pts were submitted to resection of LV fibrosis and were analyzed by MDE pre- and post-
operatively. MDE were performed in a 1.5TGE CV/I magnetic. Images were acquired
after 10-20 minutes of 0.2 mmol/kg of Gd bolus. We analyzed % LV FT (%FT)= LV FT/LV
mass.
Results: All surgical cases were confirmed as EMF during surgery and by pathology.
Data are shown in Table 1. Postsurgical LV fibrosis decreased significantly (Table I
*p<0.05, pre- vs. postsurgical).
Conclusions: MDE is useful to confirm the diagnosis of EMF by differentiating from api-
cal thrombus, hypertrophy and tumor. MDE was able to detect and quantify the fibrous
tissue in both ventricles pre- and postoperatively. Moroever, this technique provides the
precise location of fibrous tissue crucial for surgical planning.
1169-157 Cardiac Magnetic Resonance Imaging in the Diagnosis 
of Sarcoidosis
Jan-Peter Smedema, Gabriel Snoep, Marinus van Kroonenburgh, Anton Gorgels, 
Academic Hospital Maastricht, Maastricht, The Netherlands
Background: Sarcoidosis has been reported to cause clinical symptoms due to cardiac
infiltration in 5% of patients. Postmortem studies have revealed cardiac involvement in
20-50% of cases. Echocardiography, myocardial scintigraphy and myocardial biopsy suf-
fer from low sensitivity, specificity or both. Cardiac magnetic resonance (CMR) imaging
might be a valuable technique in the diagnosis of this condition.
We prospectively evaluated CMR findings in patients with various stages of sarcoidosis,
and determined sensitivity and specificity as compared to the guidelines from the Japa-
nese Ministery of Health and Welfare (1993) for the diagnosis of cardiac sarcoidosis
(gold standard).
Methods: Breath-hold functional gradient echo, T1-weigthed multislice CMR examina-
tions acquired at 1.5 T with ECG-triggering were performed before and 10 minutes after
the administration of 0.1 mmol/kg Gd-DTPA in 78 patients with various stages of sarcoi-
dosis. Ventricular function, regional wall motion, wall thickness, and the presence and
localization of Gd-enhanced lesions were assessed by two blinded observers. Additional
evaluation included physical examination, 12 lead ECG, 24-hour Holter ECG, echocar-
diography, thallium-201 scintigraphy and coronary angiography, if coronary disease was
suspected. The outcomes of the CMR studies were compared with the gold standard for
the diagnosis of cardiac sarcoidosis.
Results: 78 patients (50 male, 28 female, mean age 46,1 years, range 29-72 years) with
different stages of sarcoidosis (stage 0: 17, stage 1: 21, stage 2: 10, stage 3: 22, stage 4:
8) underwent diagnostic testing. 5 CMR studies were of insufficient image quality. In 8
patients (11%) the diagnosis of cardiac sarcoidosis was made according to the gold stan-
dard. In 6/8 patients CMR both observers found Gd-enhanced lesions with/without
Table I
Variable RV fibrotic mass 
(g)
LV fibrotic mass 
(g)
% LV fibrotic mass 
(%)
LV EMF (n=12) - 16±7 13±7




Pre- (n=6) - 19±6* 25±7*
Post- (n=6) - 14±3* 11±3*
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regional wall motion abnormalities, in 51/65 both observers agreed on the absense of
abnormalities on the CMR study. (sensitivity 75% and specificity 78%) The lesions were
most frequently located in the septal and anterolateral wall.
Conclusions: Functional and delayed enhanced CMR enables valuable detection and
localisation of cardiac sarcoidosis.
1169-158 Magnetic Resonance Imaging Can Reliably Identify 
Heart Iron Overload in Patients With B-Thalassemia 
Major
Sophie Mavrogeni, L. Kaklamanis, D. Tsiapras, I. Paraskevaidis, G. Karavolias, V. 
Markussis, M. Karagiorga, M. Douskou, D. V. Cokkinos, D. T. Kremastinos, Onassis 
Cardiac Surgery Center, Athens, Greece
Background: Patients with b-thalassemia major depend on continuous blood transfu-
sions for survival. As a consequence, iron overload occurs in all organs including the
heart. Heart biopsy is the only way to detect heart iron deposition, but it is invasive and
not easily repeatable. We applied magnetic resonance imaging (MRI) for the assessment
of myocardial iron deposition in patients with b-thalassemia and compared the results
with cardiac biopsy data.
Methods: Twenty-five consecutive thalassemic patients, NYHA II-III, were studied using
a 0.5 T system, ECG-gated, with TE=17-68 msec. T2 relaxation time of the interventricu-
lar septum was calculated assuming simple monoexponential decay in one square centi-
meter regions of interest. Heart biopsy was performed within a week after the MRI study. 
Results: Seven of the 25 patients had heart biopsy indicative of low iron deposition
(Group A) and the remaining 18 patients had heart biopsy indicative of high iron deposi-
tion (Group B). T2 relaxation time of the heart (T2H) was in agreement with heart biopsy
in 86% of the patients in Group A vs. 78% of the patients in Group B (overall agreement
80%). Similarly, serum ferritin levels were in agreement with heart biopsy in 28% vs.
88%, respectively (overall agreement 72%). In Group A, MRI was in better agreement
with biopsy compared to ferritin (86% vs. 28%, p<0.05).
Conclusions: Heart T2 relaxation time appears in agreement with cardiac biopsy, both in
high and low iron deposition, and is a useful non-invasive index for serial evaluation in b-
thalassemia.
1169-159 Myocardial Infarct Age Determined by Contrast-
Enhanced Cine Magnetic Resonance Imaging
Gilbert L. Raff, Ralph E. Gentry, James A. Goldstein, William Beaumont Hospital, Royal 
Oak, MI
Background
In patients with acute chest pain and resting wall motion abnormalities, differentiating
acute myocardial infarction (AMI) and chronic myocardial infarction (CMI) can have
important therapeutic implications. Contrast-enhanced cine magnetic resonance imaging
(CEC) has been shown to sensitively diagnose microvascular obtruction (MO), a signa-
ture of AMI that is rarely seen in CMI. The present study was designed to determine if
CEC can distinguish between AMI and CMI.
Methods
In 43 patients with enzyme-documented AMI treated by reperfusion, we performed CEC
within 36 hours of admission, and repeated this examination after 3 months. CEC imag-
ing was performed approximately 1 minute after 0.20mmol/kg of I.V. gadolinium-DTPA
contrast. Nine 8mm short-axis slices and two long-axis slices acquired, using an-EKG
gated, segmented k-space true-FISP pulse sequence. At 10 minutes post-injection, after
an inversion time scan for optimum myocardial nulling, an inversion-recovery turbo-
FLASH delayed hyperenhancement (IR-DE) study was done in identical slices. MO was
defined as discrete endocardially-based hypoenhancing regions that became all or par-
tially enhanced on IR-DE. All studies were read by two blinded observers.
Results
Microvascular obstruction on CEC was seen in 35/43 (81%) of patients with AMI, and in
only 4/43 (9%) after 3 months. The presence of MO on CEC 81% sensitive and 91% spe-
cific for AMI.
Conclusions
The presence of microvascular obstruction on contrast-enhanced cine MRI is a sensitive
and specific predictor of acute MI. Its absence suggests chronic MI.
1169-160 Systolic and Diastolic Strain Rates by Tagged Magnetic 
Resonance Imaging Distinguishes Regions With 
Different Degrees of Myocardial Injury After Acute 
Myocardial Infarction
Clerio F. Azevedo, Luciano C. Amado, Dara L. Kraitchman, Bernhard L. Gerber, Nael F. 
Osman, Carlos E. Rochitte, Thor Edvardsen, Joao A. Lima, Johns Hopkins Hospital, 
Baltimore, MD
Background: Myocardial injury after acute myocardial infarction (AMI) is a regional and
heterogeneous process that affects both systolic and diastolic function. Using tagged
MRI, we evaluated regional systolic and diastolic function in areas with different degrees
of myocardial injury after AMI and assessed whether both measures combined would
allow us to better characterize and distinguish these regions.
Methods: Fourteen dogs underwent 90-min coronary artery occlusion followed by reper-
fusion. Five short-axis slices were acquired for each dog within the first 24h of reperfu-
sion using 3 techniques: tagged MRI, first-pass perfusion and delayed-enhancement
(DE). Regional blood flow <50% of remote by radioactive microspheres during coronary
artery occlusion was used to define risk region. Each slice was divided in 6 segments
that were classified in 4 categories: transmural AMI (DE>50% area, n=95), subendocar-
dial AMI (DE<50% area, n=82), risk region (n=80) and remote area (n=163). For each
segment, circumferential systolic strain (Ecc), systolic strain rate (SSr) and early diastolic
strain rate (DSr) were calculated.
Results: Transmural AMI segments displayed depressed systolic contractility compared
to subendocardial AMI segments (P<0.01), and both showed reduced systolic and dias-
tolic regional function compared to remote areas (Ecc = –2.5±0.5% and –6.0±0.6% ver-
sus –13.1±0.5%, SSr = –0.11±0.10s–1 and –0.82±0.12s–1 versus –2.15±0.08s–1 and
DSr = 1.26±0.09s–1 and 1.50±0.08s–1 versus 2.99±0.10s–1, for transmural and suben-
docardial AMI segments versus remote areas, P<0.001 for all). In contrast, risk region
segments only exhibited diastolic impairment (DSr=1.62±0.09s–1, P<0.001 versus
remote), but not systolic dysfunction (NS versus remote). Importantly, after controlling for
segmental infarct extension, the presence of microvascular obstruction (“no reflow”) was
related to further impairment of systolic and diastolic regional function (P<0.05 for both).
Conclusion: Regional systolic and diastolic functional assessment using strain rate
analyses provides for superior characterization and distinction of regions with different
degrees of myocardial injury after AMI.
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1170-141 Initial Results Regarding the Safety, Tolerability, and 
Hemodynamic Effects of CVT-3146, a Selective 
Adenosine A2A Agonist, in Patients Undergoing 
Pharmacologic Stress SPECT Myocardial Perfusion 
Imaging
Robert C. Hendel, John J. Mahmarian, Timothy M. Bateman, Manuel D. Cerqueira, Ami 
E. Iskandrian, Markus Jerling, Hisham Y. Abdallah, Jeffrey A. Leppo, Rush University 
Medical Center, Chicago, IL
Background: CVT-3146 is a selective A2A adenosine receptor agonist shown to induce
coronary hyperemia and potentially procude less adverse effects due to its limited stimu-
lation of receptor subtypes not involved with coronary vasodilation. Thus, CVT-3146 may
be an effective pharmacologic stress agent.
Methods: We studied 36 subjects (27 men, 9 women; 67±10 years) with two doses of
CVT-3146 [400 mcg (n=18), 500 mcg (n=18)], administered by IV bolus, as part of a
pharmacologic stress SPECT myocardial perfusion imaging protocol.
Results: Adverse effects (AE) occurred in 26 subjects (72%), including chest discomfort
(33%), headache (25%), and abdominal pain (11%), with a similar incidence for both
doses. Flushing, dyspnea, and dizziness were more frequent in the 500-mcg group
(44%, 44%, and 28%, respectively) than in the 400-mcg group (17%, 17%, and 11%,
respectively). Most AE’s were mild to moderate (96%) and resolved within 15 minutes
without treatment (91%). One serious AE occurred, with exacerbation of a migraine
headache, requiring hospitalization. ST and T wave abnormalities developed with CVT-
3146 in 7 and 5 subjects, respectively. No 2nd or 3rd degree AV block was noted and
there were no serious arrhythmias. Peak hemodynamic effects were noted at 4 minutes
for systolic blood pressure (-5.9±10.7 mmHg) and within 2 minutes for heart rate
(+21.9±10.4 beats per minute). Systolic BP did not fall below 90 mmHg with either dose.
The mean change in HR response was higher for the 500 mcg dose than for 400 mcg.
Thirty minutes after CVT-3146, BP changes deviated <2% from baseline but HR
remained above baseline by 8.6%.
Conclusion: CVT-3146 is well-tolerated and has accceptable hemodynamic effects. Mini-
mal differences were noted in BP and HR responses between the 400 mcg and 500 mcg
doses, but AE’s were more frequent at the higher dose. CVT-3146 appears safe and well-
tolerated for bolus-mediated pharmacologic stress SPECT myocardial perfusion imaging.
1170-142 Differential Vasodilatory Effects of CVT-3146, an A2A 
Adenosine Receptor Agonist in Various Vascular Beds 
in Anesthetized Dogs
Arvinder K. Dhalla, Jiang Xu, William Kussmaul, Peter P. Kurnik, Amir Pelleg, Luiz 
Belardinelli, CV Therapeutics, Inc, Palo Alto, CA, Drexel University, College of Medicine, 
Philadelphia, PA
CVT-3146 is a novel selective A2A adenosine receptor agonist being developed as a
pharmacologic stressor for radionuclide myocardial perfusion imaging. Previously it has
been shown in awake dogs that CVT-3146 causes coronary vasodilation without signifi-
cantly affecting either total peripheral resistance or renal blood flow. The goal of this
study was to determine the differential effects of CVT-3146 on blood flow velocity in vari-
ous vascular beds. The effect of CVT-3146 on the blood flow velocity in the canine left cir-
cumflex coronary artery (LCX), brain arterial vasculature (BA), forelimb artery (FA) and
pulmonary artery (PA) of comparable diameters were quantified as the average peak
blood flow velocity (APV) using intravascular Doppler transducer-tipped catheter. CVT-
3146 (1.0 µg/kg) given as an intravenous bolus, transiently enhanced blood flow which
was site specific: APV increased 3.1+0.2, 1.4+0.1, 1.2+0.1, and 1.1+ 0.01 fold in the
LCX, BA, FA and PA, respectively manifesting a site-potency rank order of LCX
>>BA>FA>PA (figure). The effect of CVT-3146 on blood flow velocity was short lasting;
reaching a peak in less than 30 sec and dissipating in less than ten minutes. Increased
blood flow velocity was associated with a small transient increase in heart rate (16 bpm)
